chr2-73901264-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001615.4(ACTG2):c.-36-12G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.772 in 1,500,930 control chromosomes in the GnomAD database, including 450,845 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.76 ( 44594 hom., cov: 33)
Exomes 𝑓: 0.77 ( 406251 hom. )
Consequence
ACTG2
NM_001615.4 intron
NM_001615.4 intron
Scores
2
Splicing: ADA: 0.00001833
2
Clinical Significance
Conservation
PhyloP100: -1.08
Publications
12 publications found
Genes affected
ACTG2 (HGNC:145): (actin gamma 2, smooth muscle) Actins are highly conserved proteins that are involved in various types of cell motility and in the maintenance of the cytoskeleton. Three types of actins, alpha, beta and gamma, have been identified in vertebrates. Alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton and as mediators of internal cell motility. This gene encodes actin gamma 2; a smooth muscle actin found in enteric tissues. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Based on similarity to peptide cleavage of related actins, the mature protein of this gene is formed by removal of two N-terminal peptides.[provided by RefSeq, Dec 2010]
ACTG2 Gene-Disease associations (from GenCC):
- visceral myopathy 1Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- familial visceral myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- megacystis-microcolon-intestinal hypoperistalsis syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 2-73901264-G-C is Benign according to our data. Variant chr2-73901264-G-C is described in ClinVar as Benign. ClinVar VariationId is 1188998.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.814 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ACTG2 | ENST00000345517.8 | c.-36-12G>C | intron_variant | Intron 1 of 8 | 1 | NM_001615.4 | ENSP00000295137.3 |
Frequencies
GnomAD3 genomes AF: 0.762 AC: 115894AN: 152058Hom.: 44551 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
115894
AN:
152058
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.762 AC: 134011AN: 175786 AF XY: 0.758 show subpopulations
GnomAD2 exomes
AF:
AC:
134011
AN:
175786
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.773 AC: 1043134AN: 1348754Hom.: 406251 Cov.: 31 AF XY: 0.771 AC XY: 509896AN XY: 661494 show subpopulations
GnomAD4 exome
AF:
AC:
1043134
AN:
1348754
Hom.:
Cov.:
31
AF XY:
AC XY:
509896
AN XY:
661494
show subpopulations
African (AFR)
AF:
AC:
20694
AN:
29506
American (AMR)
AF:
AC:
27452
AN:
31360
Ashkenazi Jewish (ASJ)
AF:
AC:
16803
AN:
20656
East Asian (EAS)
AF:
AC:
18234
AN:
35822
South Asian (SAS)
AF:
AC:
46621
AN:
71446
European-Finnish (FIN)
AF:
AC:
41699
AN:
49464
Middle Eastern (MID)
AF:
AC:
4048
AN:
5340
European-Non Finnish (NFE)
AF:
AC:
825083
AN:
1049802
Other (OTH)
AF:
AC:
42500
AN:
55358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
10143
20286
30430
40573
50716
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20220
40440
60660
80880
101100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.762 AC: 115996AN: 152176Hom.: 44594 Cov.: 33 AF XY: 0.762 AC XY: 56730AN XY: 74406 show subpopulations
GnomAD4 genome
AF:
AC:
115996
AN:
152176
Hom.:
Cov.:
33
AF XY:
AC XY:
56730
AN XY:
74406
show subpopulations
African (AFR)
AF:
AC:
29110
AN:
41502
American (AMR)
AF:
AC:
12625
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
2799
AN:
3472
East Asian (EAS)
AF:
AC:
2943
AN:
5174
South Asian (SAS)
AF:
AC:
3175
AN:
4822
European-Finnish (FIN)
AF:
AC:
9023
AN:
10592
Middle Eastern (MID)
AF:
AC:
227
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53764
AN:
68000
Other (OTH)
AF:
AC:
1647
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1448
2896
4345
5793
7241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2302
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Nov 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Visceral myopathy 1 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.